Biggest News Aggregation in the World
📰 Beigene News

Page 23 - Beigene News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.

Fierce Pharma Asia—Legend, J&J's CAR-T delay; BeiGene's Brukinsa data; Samsung Biologics CEO interview

Legend Biotech and Johnson & Johnson have to wait three more months for an FDA decision on their CAR-T medicine. BeiGene's Brukinsa posts competitive frontline leukemia data as key BTK showdown nears. Samsung Biologics' newly minted CEO talks about the CDMO's rapid expansion. And more.
New Jersey United States South Korea South Korean Clay Siegall Roche Rituxan

Shoreline Biosciences secures $140M for off-the-shelf NK cell therapies for cancer

Gilead Sciences and BeiGene, which started research alliances with Shoreline Biosciences earlier this year, are among the investors in the biotech's latest financing. The preclinical-stage company technology develops cell therapies for cancer by using natural killer cells.
Artiva Biosciences Frank Yu Allen Institute Of Artificial Intelligence Gilead Sciences Diego Based Shoreline Beijing Based Beigene

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bristol Myers Squibb is nixing BeiGene's Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame?

A partnership between Bristol Myers Squibb and BeiGene on the chemotherapy Abraxane in China has quickly deteriorated since a manufacturing-related marketing hold last March. Now, the U.S. pharma is scrapping the deal—much to the Chinese partner’s disagreement.
New York United States Andrew Berens Fresenius Kabi China National Medical Products Administration International Chamber

中国百济神州称FDA授予"百悦泽"加速批准用于治疗复发或难治性边缘区淋巴瘤

中国生物制药公司--百济神州<BGNE.O><6160.HK>周三晚间公告称,美国食品药品监督管理局(FDA)已授予百悦泽(泽布替尼)加速批准,用于治疗复发或难治性边缘区淋巴瘤。
United States Hong Kong Celeste Juan Beijing China Divine Monday ஒன்றுபட்டது மாநிலங்களில்

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science